Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • ABF Journal Pulse
    • Resolving MCA Distress
  • Recruiting
  • Events
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • ABF Journal Pulse
    • Resolving MCA Distress
  • Recruiting
  • Events
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home News

Axiom Donates $200K to Support Emory University Brain Disease Research

byAmanda Koprowski
May 16, 2019
in News

Florida-based community bank Axiom Bank donated $200,000 to the Emory Brain Health Center. This gift will help fund further research aimed at developing new treatments for brain diseases such as epilepsy, Parkinson’s and depression through the Emory Neuromodulation and Technology Innovation Center (ENTICe).

“Axiom Bank is deeply committed to social responsibility,” said Daniel Davis, Axiom president and CEO. “Our support for ENTICe will help to foster vital medical research that one day will result in life-changing treatments for devastating neurological diseases.”

ENTICe is a collaborative effort between the Emory University departments of neurosurgery, neurology, and psychiatry and behavioral sciences in partnership with scientists and biomedical engineers from Georgia Tech. They work together to facilitate research and technical investigation, developing more effective medical devices and strategies to improve neuromodulation treatments for brain disorders.

“This generous contribution from Axiom Bank will help us continue our work in a variety of ways including our efforts to develop novel therapies for patients with drug resistant epilepsy and Parkinson’s disease,” says Robert E. Gross, MD, PhD, director and co-founder of ENTICe and professor of neurosurgery, neurology, biomedical engineering and neuroscience at Emory University School of Medicine.

Previous Post

WFCF Promotes Morrone, Pfeiffer to Lead Channel Finance Division

Next Post

Abraham to Succeed Lammers as Head of Byline Bank SBC

Related Posts

Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Ares Commercial Finance Provides $25MM in Senior Secured Financing for Real Good Foods

September 10, 2026
Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Pathlight Capital Serves as Administrative Agent on $60MM Senior Secured Term Loan to Lifetime Brands

September 10, 2026
Deal Announcements

TradeCap Partners Provides $7.5MM PO Facility to Importer of Warehouse Rack Systems and Carts

September 10, 2026
News

Advantage Business Capital Welcomes Garcia as VP, ABL Underwriter

September 10, 2026
GoldenTree Asset Management Hires Conti as Chief Financial Officer
News

GoldenTree Asset Management Hires Conti as Chief Financial Officer

September 10, 2026
Wingspire Capital Provides Over $500MM in Corporate Finance Commitments in H1/25
News

Richelle Kalnit Launches Silhouette Advisors

September 10, 2026
Next Post

Abraham to Succeed Lammers as Head of Byline Bank SBC

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

TMA Leading Edge Series with Matthew English: Decision Paralysis: A Barrier to Turnaround

TMA Leading Edge Series with Matthew English: Decision Paralysis: A Barrier to Turnaround

August 14, 2026

Capital, Consolidation & Conspicuous Consumption: The Gilded Age Captains of Industry

August 27, 2026

Slowing Growth, Rising Stress: What the Middle Market’s Diverging Credit Signals Mean for Lenders and Sponsors

August 21, 2026

Stopping MCA Withdrawals: Why an “MCA Attorney” May Not Be the First Call

August 14, 2026

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • ABF Journal Pulse
    • Resolving MCA Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years